ID   SSH3_HUMAN              Reviewed;         659 AA.
AC   Q8TE77; Q6PK42; Q76I75; Q8N9L8; Q8WYL0; Q9NV45; Q9NWZ7;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   22-NOV-2005, sequence version 2.
DT   10-MAY-2017, entry version 134.
DE   RecName: Full=Protein phosphatase Slingshot homolog 3;
DE            EC=3.1.3.16;
DE            EC=3.1.3.48;
DE   AltName: Full=SSH-like protein 3;
DE            Short=SSH-3L;
DE            Short=hSSH-3L;
GN   Name=SSH3; Synonyms=SSH3L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=11832213; DOI=10.1016/S0092-8674(01)00638-9;
RA   Niwa R., Nagata-Ohashi K., Takeichi M., Mizuno K., Uemura T.;
RT   "Control of actin reorganization by Slingshot, a family of
RT   phosphatases that dephosphorylate ADF/cofilin.";
RL   Cell 108:233-246(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=14531860; DOI=10.1046/j.1365-2443.2003.00678.x;
RA   Ohta Y., Kousaka K., Nagata-Ohashi K., Ohashi K., Muramoto A.,
RA   Shima Y., Niwa R., Uemura T., Mizuno K.;
RT   "Differential activities, subcellular distribution and tissue
RT   expression patterns of three members of Slingshot family phosphatases
RT   that dephosphorylate cofilin.";
RL   Genes Cells 8:811-824(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3; 4 AND 5).
RC   TISSUE=Cerebellum, and Ovarian carcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85 AND SER-87, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9 AND SER-37, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9; SER-37 AND SER-87,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Protein phosphatase which may play a role in the
CC       regulation of actin filament dynamics. Can dephosphorylate and
CC       activate the actin binding/depolymerizing factor cofilin, which
CC       subsequently binds to actin filaments and stimulates their
CC       disassembly (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- SUBUNIT: Does not bind to, or colocalize with, filamentous actin.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}.
CC       Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=L;
CC         IsoId=Q8TE77-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TE77-2; Sequence=VSP_016335, VSP_016336;
CC       Name=3;
CC         IsoId=Q8TE77-3; Sequence=VSP_016331, VSP_016332;
CC       Name=4;
CC         IsoId=Q8TE77-4; Sequence=VSP_016333;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q8TE77-5; Sequence=VSP_016330, VSP_016334, VSP_016335,
CC                                  VSP_016336;
CC         Note=No experimental confirmation available.;
CC   -!- MISCELLANEOUS: Tyrosine phosphatase activity has not been
CC       demonstrated for this protein to date.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB072360; BAB84119.3; -; mRNA.
DR   EMBL; AB099291; BAC97814.1; -; mRNA.
DR   EMBL; AK000522; BAA91228.1; -; mRNA.
DR   EMBL; AK001790; BAA91913.1; -; mRNA.
DR   EMBL; AK074432; BAB85080.1; -; mRNA.
DR   EMBL; AK094226; BAC04314.1; -; mRNA.
DR   EMBL; BC007709; AAH07709.1; -; mRNA.
DR   CCDS; CCDS8157.1; -. [Q8TE77-1]
DR   RefSeq; NP_060327.3; NM_017857.3. [Q8TE77-1]
DR   UniGene; Hs.29173; -.
DR   ProteinModelPortal; Q8TE77; -.
DR   SMR; Q8TE77; -.
DR   BioGrid; 120299; 16.
DR   IntAct; Q8TE77; 5.
DR   MINT; MINT-5006487; -.
DR   STRING; 9606.ENSP00000312081; -.
DR   DEPOD; Q8TE77; -.
DR   iPTMnet; Q8TE77; -.
DR   PhosphoSitePlus; Q8TE77; -.
DR   BioMuta; SSH3; -.
DR   DMDM; 82582268; -.
DR   EPD; Q8TE77; -.
DR   MaxQB; Q8TE77; -.
DR   PaxDb; Q8TE77; -.
DR   PeptideAtlas; Q8TE77; -.
DR   PRIDE; Q8TE77; -.
DR   DNASU; 54961; -.
DR   Ensembl; ENST00000308127; ENSP00000312081; ENSG00000172830. [Q8TE77-1]
DR   Ensembl; ENST00000376757; ENSP00000365948; ENSG00000172830. [Q8TE77-3]
DR   Ensembl; ENST00000532881; ENSP00000431788; ENSG00000172830. [Q8TE77-2]
DR   GeneID; 54961; -.
DR   KEGG; hsa:54961; -.
DR   UCSC; uc001okj.4; human. [Q8TE77-1]
DR   CTD; 54961; -.
DR   GeneCards; SSH3; -.
DR   HGNC; HGNC:30581; SSH3.
DR   HPA; HPA019949; -.
DR   HPA; HPA019957; -.
DR   MIM; 606780; gene.
DR   neXtProt; NX_Q8TE77; -.
DR   OpenTargets; ENSG00000172830; -.
DR   PharmGKB; PA134929326; -.
DR   eggNOG; KOG1716; Eukaryota.
DR   eggNOG; COG2453; LUCA.
DR   GeneTree; ENSGT00760000118902; -.
DR   HOVERGEN; HBG089321; -.
DR   InParanoid; Q8TE77; -.
DR   KO; K05766; -.
DR   OMA; GPWPALK; -.
DR   OrthoDB; EOG091G0249; -.
DR   PhylomeDB; Q8TE77; -.
DR   TreeFam; TF319444; -.
DR   SIGNOR; Q8TE77; -.
DR   GeneWiki; SSH3; -.
DR   GenomeRNAi; 54961; -.
DR   PRO; PR:Q8TE77; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000172830; -.
DR   CleanEx; HS_SSH3; -.
DR   ExpressionAtlas; Q8TE77; baseline and differential.
DR   Genevisible; Q8TE77; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003779; F:actin binding; IBA:GO_Central.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro.
DR   GO; GO:0008064; P:regulation of actin polymerization or depolymerization; IBA:GO_Central.
DR   GO; GO:0050770; P:regulation of axonogenesis; IBA:GO_Central.
DR   GO; GO:0010591; P:regulation of lamellipodium assembly; IBA:GO_Central.
DR   CDD; cd00127; DSPc; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR014876; DEK_C.
DR   InterPro; IPR000340; Dual-sp_phosphatase_cat-dom.
DR   InterPro; IPR024950; DUSP.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR027232; Ssh.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   InterPro; IPR020422; TYR_PHOSPHATASE_DUAL_dom.
DR   PANTHER; PTHR10159; PTHR10159; 1.
DR   PANTHER; PTHR10159:SF455; PTHR10159:SF455; 1.
DR   Pfam; PF08766; DEK_C; 1.
DR   Pfam; PF00782; DSPc; 1.
DR   SMART; SM00195; DSPc; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50054; TYR_PHOSPHATASE_DUAL; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Hydrolase; Nucleus; Phosphoprotein; Polymorphism;
KW   Protein phosphatase; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:Q8K330}.
FT   CHAIN         2    659       Protein phosphatase Slingshot homolog 3.
FT                                /FTId=PRO_0000094845.
FT   DOMAIN      328    468       Tyrosine-protein phosphatase.
FT   ACT_SITE    413    413       Phosphocysteine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10044}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000250|UniProtKB:Q8K330}.
FT   MOD_RES       9      9       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      37     37       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      85     85       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES      87     87       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1    330       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_016330.
FT   VAR_SEQ       1    146       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_016331.
FT   VAR_SEQ     147    154       LGVDFPDS -> MAFPLSPA (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_016332.
FT   VAR_SEQ     283    547       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_016333.
FT   VAR_SEQ     331    360       RIFPHLYLGSEWNAANLEELQRNRVTHILN -> MEGTMMM
FT                                QQRPVLSQQHPSFILNSSPAHSP (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_016334.
FT   VAR_SEQ     470    471       SR -> RT (in isoform 2 and isoform 5).
FT                                {ECO:0000303|PubMed:11832213,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_016335.
FT   VAR_SEQ     472    659       Missing (in isoform 2 and isoform 5).
FT                                {ECO:0000303|PubMed:11832213,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_016336.
FT   VARIANT     239    239       E -> V (in dbSNP:rs7114712).
FT                                /FTId=VAR_057132.
FT   VARIANT     600    600       R -> H (in dbSNP:rs1573536).
FT                                /FTId=VAR_057133.
FT   CONFLICT     58     58       A -> V (in Ref. 1 and 2). {ECO:0000305}.
FT   CONFLICT    509    509       E -> G (in Ref. 3; BAC04314).
FT                                {ECO:0000305}.
FT   CONFLICT    641    641       F -> S (in Ref. 3; BAB85080).
FT                                {ECO:0000305}.
SQ   SEQUENCE   659 AA;  72996 MW;  0D96F86EAFE81D3B CRC64;
     MALVTVSRSP PGSGASTPVG PWDQAVQRRS RLQRRQSFAV LRGAVLGLQD GGDNDDAAEA
     SSEPTEKAPS EEELHGDQTD FGQGSQSPQK QEEQRQHLHL MVQLLRPQDD IRLAAQLEAP
     RPPRLRYLLV VSTREGEGLS QDETVLLGVD FPDSSSPSCT LGLVLPLWSD TQVYLDGDGG
     FSVTSGGQSR IFKPISIQTM WATLQVLHQA CEAALGSGLV PGGSALTWAS HYQERLNSEQ
     SCLNEWTAMA DLESLRPPSA EPGGSSEQEQ MEQAIRAELW KVLDVSDLES VTSKEIRQAL
     ELRLGLPLQQ YRDFIDNQML LLVAQRDRAS RIFPHLYLGS EWNAANLEEL QRNRVTHILN
     MAREIDNFYP ERFTYHNVRL WDEESAQLLP HWKETHRFIE AARAQGTHVL VHCKMGVSRS
     AATVLAYAMK QYECSLEQAL RHVQELRPIA RPNPGFLRQL QIYQGILTAS RQSHVWEQKV
     GGVSPEEHPA PEVSTPFPPL PPEPEGGGEE KVVGMEESQA APKEEPGPRP RINLRGVMRS
     ISLLEPSLEL ESTSETSDMP EVFSSHESSH EEPLQPFPQL ARTKGGQQVD RGPQPALKSR
     QSVVTLQGSA VVANRTQAFQ EQEQGQGQGQ GEPCISSTPR FRKVVRQASV HDSGEEGEA
//
